€289.85
1.10% today
L&S, Jul 04, 09:10 am CET
ISIN
US0311621009
Symbol
AMGN
Sector
Industry

Amgen Share price

$309.38
+1.96 0.64% 1M
+8.69 2.89% 6M
+21.36 7.42% YTD
+84.37 37.50% 1Y
+60.68 24.40% 3Y
+120.80 64.06% 5Y
+186.53 151.84% 10Y
NYSE, Closing price Wed, Jul 03 2024
-1.39 0.45%
ISIN
US0311621009
Symbol
AMGN
Sector
Industry

Key metrics

Market capitalization $165.96b
Enterprise Value $220.27b
PER (TTM) P/E ratio 44.24
EV/FCF (TTM) EV/FCF 31.03
EV/Sales (TTM) EV/Sales 7.50
P/S ratio (TTM) P/S ratio 5.65
P/B ratio (TTM) P/B ratio 33.04
Dividend yield 2.75%
Last dividend (FY23) $8.52
Sales growth (TTM) Sales growth 13.18%
Turnover (TTM) Turnover $29.35b
EBIT (operating result TTM) EBIT $7.29b
Free cash flow (TTM) Free cash flow $7.10b
Cash position $9.71b
EPS (TTM) EPS $6.99
P/E ratio expected 35.93
P/S ratio expected 5.03
EV/Sales expected 6.68
Short interest 1.70%
Show more

Create a Free Account to create an Amgen alert.

Set up alerts on Stock Price, Dividend Yield, Valuation (e.g. P/E or EV/Sales) or Strategy Scores and sit back and relax.

Amgen Share analysis

Analyst opinions

29 Analysts have issued a Amgen forecast:

14x Buy
48%
13x Hold
45%
2x Sell
7%

Analyst opinions

29 Analysts have issued a Amgen forecast:

Buy
48%
Hold
45%
Sell
7%

Financial data from Amgen

Mar '24
+/-
%
Net profit 3,763 3,763
52% 52%
13%
Depreciation and amortization 4,570 4,570
30% 30%
16%
Share compensation - -
-
-
Operating cash flow 8,096 8,096
6% 6%
28%
Investments 998 998
8% 8%
3%
Dividend paid 4,627 4,627
9% 9%
16%
Free cash flow 7,098 7,098
6% 6%
24%

Figures in millions USD.

Don't miss a thing! We will send you all news about the Amgen share directly to your mailbox free of charge.

If you wish, you can receive an e-mail every morning in time for breakfast containing all the stock news relevant to you.

Amgen Share News

Positive
Seeking Alpha
about 11 hours ago
"The Dow® [adds a stock] if the company has an excellent reputation, demonstrates sustained growth, and is of interest to numerous investors
Positive
The Motley Fool
5 days ago
Amgen has maintained an impressive dividend streak over the past decade. The company's business should allow it to maintain this momentum for a while.
Positive
24/7 Wall Street
7 days ago
24/7 Wall St. Insights Jefferies is one of Wall Street's fastest-growing firms.
More Amgen News

Company profile

Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture and marketing of human therapeutics. Its products include the following brands: Aranesp, BLINCYTO, Corlanor, ENBREL, EPOGEN, IMLYGIC, KYPROLIS, Neulasta, NEUPOGEN, Nplate, Parsabiv, Prolia, Repatha, Sensipar, Vectibix, and XGEVA. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.

Head office United States
CEO Robert Bradway
Employees 26,700
Founded 1980
Website www.amgen.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today